Welcome to LookChem.com Sign In|Join Free
The company logo of Hebei KuiSheng Trading Co., LTD

Hebei KuiSheng Trading Co., LTD

Assessed Supplier

Assessed
Supplier
1st
years

Hebei KuiSheng Trading Co., LTD

Business Type:Trading Company

Main Products:
Year Established:
2024
Home>>Products>>Fluoxetine

Product Certification&
Enterprise Certification

More Detail

Hebei KuiSheng Trading Co., LTD

Country: China (Mainland)

Business Type:Trading Company

Mr.li

Tel: 15350525905

Mr.Sally

Tel: 13315186550

Ms.Adeline

Tel: 17798195659

Ms.Verna

Tel: 19061935658

Mobile:

Tel: 15350525905

Fax:

URL: http://

Province/state: Hebei

City: Shijiazhuang

Street: 518, Mansion No. 3, Guang 'an Street, Chang 'an District, Shijiazhuang, Hebei

MaxCard:


Contact Suppliers

Fluoxetine

CAS NO.54910-89-3

  • Min.Order: 10 Gram
  • Payment Terms: T/T,Other
  • Available Specifications:

Contact Supplier

Product Details

Keywords

  • Fluoxetine
  • 54910-89-3
  • C17h18f3no

Quick Details

  • ProName: Fluoxetine
  • CasNo: 54910-89-3
  • Molecular Formula: C17h18f3no
  • Appearance: Powder
  • Application: Pharmaceutical industry
  • DeliveryTime: Stock
  • PackAge: 1kg Per Bag, 25kg Per Drum
  • Port: Shanghai/tianjin
  • ProductionCapacity: 50 Kilogram/Week
  • Purity: 99%
  • Storage: Store at -20°C
  • Transportation: According to customer requirements
  • LimitNum: 10 Gram

Superiority

Function
Fluoxetine was shown to be effective for depression in six-week-long double-blind controlled trials, where it also alleviated anxiety and improved sleep. Fluoxetine was better than placebo for the prevention of depression recurrence when the patients, who originally responded to fluoxetine, were treated for a further 38 weeks. Efficacy of fluoxetine for geriatric, as well as pediatric, depression was also demonstrated in placebo-controlled trials.

Research suggests that a significant part of the resistance to the SSRIs paroxetine (Paxil) and citalopram(Celexa) can be explained by the genetic variation of Pgp transporter. Paroxetine and citalopram, which are Pgp substrates, are actively transported from the brain by this protein. Fluoxetine is not a substrate of Pgp, and thus a switch from paroxetine or citalopram to fluoxetine may be beneficial to the nonresponders.


Fluoxetine is frequently used to treat major depression, obsessive compulsive disorder, bulimia nervosa,panic disorder, body dysmorphic disorder, premenstrual dysphoric disorder, and trichotillomania. Caution should be taken when using any SSRI for bipolar disorder as this can increase the likelihood of mania; however, fluoxetine can be used with an antipsychotic (such as quetiapine) for bipolar. It has also been used for cataplexy, obesity, and alcohol dependence,as well as binge eating disorder.
 

20mg each time, 1 times, every morning to take, if after a few weeks the curative effect is not obvious to 20mg each time, two times a day (early, late each time), but the daily dosage of not more than 80mg

 

 

Our own factory produces direct sales with absolute price advantage

Details

.What is Fluoxetine ?


Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant. Fluoxetine inhibits the uptake of serotonin by a nerve cells (neurons) and helps people with depression, panic, anxiety, or obsessive-compulsive symptoms.

Fluoxetine is a prescription medicine used to treat major depressive disorder, bulimia nervosa (an eating disorder), obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD).
 

3.How does Fluoxetine work?

Fluoxetine binds to the presynaptic serotonin receptor resulting in negative allosteric modulation of the receptor complex, thereby blocking recycling of serotonin by the presynaptic receptor. Inhibition of serotonin reuptake by fluoxetine enhances serotonergic function through serotonin accumulation in the synaptic space, resulting in long-term desensitization and downregulation of 5HT1 (serotonin) receptors leading to antidepressant, antiobsessional and antibulimic effects via various nerve pathways in the brain.



4.What's the main function of Fluoxetine?

Fluoxetine was shown to be effective for depression in six-week-long double-blind controlled trials, where it also alleviated anxiety and improved sleep. Fluoxetine was better than placebo for the prevention of depression recurrence when the patients, who originally responded to fluoxetine, were treated for a further 38 weeks. Efficacy of fluoxetine for geriatric, as well as pediatric, depression was also demonstrated in placebo-controlled trials.

Research suggests that a significant part of the resistance to the SSRIs paroxetine (Paxil) and citalopram(Celexa) can be explained by the genetic variation of Pgp transporter. Paroxetine and citalopram, which are Pgp substrates, are actively transported from the brain by this protein. Fluoxetine is not a substrate of Pgp, and thus a switch from paroxetine or citalopram to fluoxetine may be beneficial to the nonresponders.

Fluoxetine is frequently used to treat major depression, obsessive compulsive disorder, bulimia nervosa,panic disorder, body dysmorphic disorder, premenstrual dysphoric disorder, and trichotillomania. Caution should be taken when using any SSRI for bipolar disorder as this can increase the likelihood of mania; however, fluoxetine can be used with an antipsychotic (such as quetiapine) for bipolar. It has also been used for cataplexy, obesity, and alcohol dependence,as well as binge eating disorder.



Medical uses:

Fluoxetine is frequently used to treat major depressive disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bulimia nervosa, panic disorder, premenstrual dysphoric disorder, and trichotillomania.It has also been used for cataplexy, obesity, and alcohol dependence,as well as binge eating disorder.It has also been tried as a treatment for autism spectrum disorders with moderate success in adults.

Obsessive-compulsive disorder:

The efficacy of fluoxetine in the treatment of obsessive-compulsive disorder (OCD) was demonstrated in two randomized multicenter phase III clinical trials. The pooled results of these trials demonstrated that 47% of completers treated with the highest dose were "much improved" or "very much improved" after 13 weeks of treatment, compared to 11% in the placebo arm of the trial.The American Academy of Child and Adolescent Psychiatry state that SSRIs, including fluoxetine, should be used as first-line therapy in children, along with cognitive behavioral therapy (CBT), for the treatment of moderate to severe OCD.

Panic disorder:

The efficacy of fluoxetine in the treatment of panic disorder was demonstrated in two 12-week randomized multicenter phase III clinical trials that enrolled patients diagnosed with panic disorder, with or without agoraphobia. In the first trial, 42% of subjects in the fluoxetine-treated arm were free of panic attacks at the end of the study, vs. 28% in the placebo arm. In the second trial, 62% of fluoxetine treated patients were free of panic attacks at the end of the study, vs. 44% in the placebo arm.

Bulimia nervosa:

A 2011 systematic review of seven trials which compared fluoxetine to a placebo in the treatment of bulimia nervosa; six of which found a statistically significant reduction in symptoms such as vomiting and binge eating.However, no difference was observed between treatment arms when fluoxetine and psychotherapy were compared to psychotherapy alone.

Gabapentin is an anticonvulsant that is chemically unrelated to any other anticonvulsant or mood regulating medication. Gabapentin
received final approval for marketing in the USA on 30 December 1993 and is labeled only for use as an anticonvulsant.It is also

widely used to treat individuals suffering from many kinds of pain problems, tremors,restless legs syndrome, hot flashes associated

with menopause, and various psychiatric disorders.